Document Classification

Section Type: RESULTS

Text: All the inflammation markers significantly (P < 0. 05) decreased in the pentoxifylline group : TNF - [baseline 0. 4 (0-2) versus final 0 (0-0) pg/mL], IL-6 [baseline 9. 4 (5-14) versus final 2. 9 (2-5) pg/mL] and CRP [baseline 7. 1 (3-20) versus final 2. 6 (1-8) mg/L], whereas no significant changes were observed in the placebo group : TNF - [baseline 0 (0-0) versus final 1. 2 (0-4) pg/mL], IL-6 [baseline 8. 0 (5-11) versus final 8. 7 (4-11) pg/mL] and CRP [baseline 4. 5 (2-9) versus final 3. 8 (3-23) mg/L].